Business · 24/08/2007
FDA Releases Guidance on Hepatitis C Virus (HCV) Lookback Requirements
The Food and Drug Administration (FDA) has made available a document outlining recommendations for complying with the HCV 'Lookback' requirements, which were finalized after a previous draft guidance and supersede an earlier memorandum on hepatitis B and C virus quarantines.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →